Gracell Biotechnologies Inc. - stock earnings
GRCL Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -9.3 million USD | ? USD |
| 2023Q2 | -20.3 million USD | ? USD |
| 2023Q1 | -19.0 million USD | ? USD |
| 2022Q4 | -19.0 million USD | ? USD |
| 2022Q3 | -24.2 million USD | ? USD |
| 2022Q2 | -21.7 million USD | ? USD |
| 2022Q1 | -20.3 million USD | ? USD |
| 2021Q4 | -20.2 million USD | ? USD |
| 2021Q3 | -20.1 million USD | 56785 USD |
| 2021Q2 | -14.9 million USD | ? USD |
| 2021Q1 | -12.8 million USD | ? USD |
| 2020Q4 | -12.8 million USD | ? USD |
| 2020Q3 | -7.4 million USD | ? USD |
| 2020Q2 | -6.5 million USD | ? USD |
| 2020Q1 | -4.5 million USD | ? USD |
| 2019Q4 | -6.1 million USD | ? USD |
| 2019Q2 | -5.0 million USD | ? USD |
| 2019Q1 | -5.2 million USD | ? USD |
| 2018Q4 | -5.0 million USD | ? USD |
| 2018Q2 | -2.3 million USD | ? USD |
| 2018Q1 | -2.4 million USD | ? USD |
| 2017Q4 | -2.3 million USD | ? USD |
GRCL Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -70.2 million USD | ? USD |
| 2022 | -88.2 million USD | ? USD |
| 2021 | -73.3 million USD | 57602 USD |
| 2020 | -30.2 million USD | ? USD |
| 2019 | -18.9 million USD | ? USD |
| 2018 | -8.8 million USD | ? USD |
GRCL
Price: $10.25
52 week price:
Earnings Per Share: -0.96 USD
P/E Ratio: -10.59
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1.0 million
Market Capitalization: 989.9 million